期刊文献+

n-3多不饱和脂肪酸与儿童生长发育和健康 被引量:9

Beneficial effects of n - 3 polyunsaturated fatty acids on child development and health
原文传递
导出
摘要 n-3多不饱和脂肪酸(n-3 PUFAs)作为膳食必需脂肪酸,具有广泛的生物学功能;现代人膳食n-3 PUFAs摄入处于相对或绝对缺乏状态。生命早期足量n-3 PUFAs的摄入,不仅对于保证胎儿及婴幼儿的正常生长发育至关重要,还有助于预防儿童青少年期注意力缺陷多动障碍、哮喘及过敏性疾病、高脂血症、非酒精性脂肪肝等慢性非感染性疾病的发生。人体利用前体亚麻酸(LNA)合成极长链的二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)的能力有限,必须摄取现成的EPA和DHA以满足机体的需求。对于孕妇以及婴幼儿来说,补充DHA和EPA的比例宜保持在5∶1以上。临床上,EPA和DHA已被用于上述这些慢性非感染性疾病的辅助治疗,可有效改善临床表现。 n-3 polyunsaturated fatty acids (n-3 PUFAs), essential fatty acids for human body, have varied biological activities.They are absolutely or relatively deficient in modern human diets.Supplementation of n-3 PUFAs in early life is important for the optimal growth and development in fetus, infants and children, and well as for prevention of chronic non-communicable diseases in later life, such as attention deficient hyperactivity disorder, allergic diseases, asthma, hyperlipidemia and non-alcoholic fatty liver disease.The human body can synthesize eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with linolenic acid, but the ability is limited.Therefore, intake of pre-formed EPA and DHA is needed for body requirement.For pregnant women and infants, supplementation of DHA and EPA with a ratio above 5∶1 is suggested.In clinic, n-3 PUFAs have been applied for treatment of chronic non-communicable diseases and proved to be beneficial in relief of symptoms.
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2016年第23期1761-1765,共5页 Chinese Journal of Applied Clinical Pediatrics
关键词 N-3多不饱和脂肪酸 发育 慢性非感染性疾病 儿童 n - 3 polyunsaturated fatty acids Development Chronic non - communicable diseases Child
  • 相关文献

参考文献2

二级参考文献28

  • 1马文军,许燕君,傅传喜,陈美芬,徐浩锋,李剑森,聂少萍,李海康.广东省6188名3至14岁儿童血脂水平及影响因素分析[J].中华心血管病杂志,2005,33(10):950-955. 被引量:18
  • 2刘颖,米杰,杜军保.北京地区6~18岁儿童血脂紊乱现况调查[J].中国实用儿科杂志,2007,22(2):101-102. 被引量:32
  • 3万乃君,米杰,王天有,段佳丽,黎明,巩纯秀,杜军保,赵小元,程红,侯冬青,王俐.北京市超重和肥胖学龄儿童中代谢综合征的流行特征[J].中华儿科杂志,2007,45(6):417-421. 被引量:47
  • 4Rahalkar AR,Hegele RA. Monogenic pediatric dyslipidemias:classification,genetics and clinical spectrum[J].{H}Molecular Genetics and Metabolism,2008,(03):282-294.
  • 5Iughetti L,Bruzzi P,Predieri B. Evaluation and management of hyperlipidemia in children and adolescents[J].{H}Current Opinion in Pediatrics,2010,(04):485-493.
  • 6Kwiterovich PO. Clinical implications of the molecular basis of familial hypercholesterolemia and other inherited dyslipidemias[J].{H}CIRCULATION,2011,(11):1153-1155.
  • 7Johansen CT,Hegele RA. The complex genetic basis of plasma triglycerides[J].{H}Curren Atherosclerosis Report,2012,(03):227-234.
  • 8Goldberg AC,Hopkins PN,Toth PP. Familial hypercholesterolemia:screening,diagnosis and management of pediatric and adult patients:clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia[J].J Clin Lipidol,2011,(03):133-140.
  • 9Descamps OS,Tenoutasse S,Stephenne X. Management of familial hypercholesterolemia in children and young adults:consensus paper developed by a panel of lipidologists,cardiologists,paediatricians,nutritionists,gastroenterologists,general practitioners and a patient organization[J].{H}ATHEROSCLEROSIS,2011,(02):272-280.
  • 10Kit BK,Carroll MD,Lacher DA. Trends in serum lipids among US youths aged 6 to 19 years,1988-2010[J].{H}JAMA:the Journal of the American Medical Association,2012,(06):591-600.

共引文献4

同被引文献90

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部